마크로시클릭 화합물 및 그의 용도

본 발명은, 임의적으로 제약상 허용되는 담체 중, 종양 혈관 재형성 효과 및/또는 항-CAF (암 연관 섬유모세포) 활성을 갖는 신규 화합물 (1) 또는 그의 제약상 허용되는 염, 및 그의 의학적 용도를 제공한다. The present invention provides novel Compound (1) having tumor vascular remodeling effect and/or anti-CAF (Cancer Associated Fibroblasts) activity, or a pharmaceutically acceptable...

Full description

Saved in:
Bibliographic Details
Main Authors KISHI YOSHITO, KIRA KAZUNOBU, ITO KEN
Format Patent
LanguageKorean
Published 10.12.2019
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 본 발명은, 임의적으로 제약상 허용되는 담체 중, 종양 혈관 재형성 효과 및/또는 항-CAF (암 연관 섬유모세포) 활성을 갖는 신규 화합물 (1) 또는 그의 제약상 허용되는 염, 및 그의 의학적 용도를 제공한다. The present invention provides novel Compound (1) having tumor vascular remodeling effect and/or anti-CAF (Cancer Associated Fibroblasts) activity, or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier, and medical uses thereof.
AbstractList 본 발명은, 임의적으로 제약상 허용되는 담체 중, 종양 혈관 재형성 효과 및/또는 항-CAF (암 연관 섬유모세포) 활성을 갖는 신규 화합물 (1) 또는 그의 제약상 허용되는 염, 및 그의 의학적 용도를 제공한다. The present invention provides novel Compound (1) having tumor vascular remodeling effect and/or anti-CAF (Cancer Associated Fibroblasts) activity, or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable carrier, and medical uses thereof.
Author KISHI YOSHITO
KIRA KAZUNOBU
ITO KEN
Author_xml – fullname: KISHI YOSHITO
– fullname: KIRA KAZUNOBU
– fullname: ITO KEN
BookMark eNrjYmDJy89L5WTQe728423jmtcL57zpnvO2ccvrZWsV3s6c8nbqytdr9ii83tCv8Gr7jjdzZyi8mbXydX8LDwNrWmJOcSovlOZmUHZzDXH20E0tyI9PLS5ITE7NSy2J9w4yMjC0NDA0Njc0MnQ0Jk4VAKsZOl0
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20190137121A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20190137121A3
IEDL.DBID EVB
IngestDate Fri Sep 06 06:15:30 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20190137121A3
Notes Application Number: KR20197032300
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191210&DB=EPODOC&CC=KR&NR=20190137121A
ParticipantIDs epo_espacenet_KR20190137121A
PublicationCentury 2000
PublicationDate 20191210
PublicationDateYYYYMMDD 2019-12-10
PublicationDate_xml – month: 12
  year: 2019
  text: 20191210
  day: 10
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies PRESIDENT AND FELLOWS OF HARVARD COLLEGE
EISAI R&D MANAGEMENT CO., LTD
RelatedCompanies_xml – name: EISAI R&D MANAGEMENT CO., LTD
– name: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Score 3.2117674
Snippet 본 발명은, 임의적으로 제약상 허용되는 담체 중, 종양 혈관 재형성 효과 및/또는 항-CAF (암 연관 섬유모세포) 활성을 갖는 신규 화합물 (1) 또는 그의 제약상 허용되는 염, 및 그의 의학적 용도를 제공한다. The present invention provides novel...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 마크로시클릭 화합물 및 그의 용도
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191210&DB=EPODOC&locale=&CC=KR&NR=20190137121A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUmxtEwBNtp0DUwS03RNLMzSdC2BtbhuqkWyebJhcmKaCXhTmK-fmUeoiVeEaQQTQw5sLwz4nNBy8OGIwByVDMzvJeDyugAxiOUCXltZrJ-UCRTKt3cLsXVRg_aOgZ0PYBdGzcXJ1jXA38XfWc3Z2dY7SM0vCCwHOl0PKO_IzMAKakiDTtp3DXMC7UspQK5U3AQZ2AKA5uWVCDEwZecLM3A6w-5eE2bg8IVOeQOZ0NxXLMKg93p5x9vGNa8XznnTPedt45bXy9YqvJ055e3Ula_X7FF4vaFf4dX2HW_mzlB4M2vl6_4WUQZlN9cQZw9doMXxcH_Gewchu9JYjIElLz8vVYJBITXZxCLV3DjRMDkJ2HxJNLVIAjYC0oxNkhLNEhNNkxMlGWTwmSSFX1qagQvEBa3RMDSQYWApKSpNlQXWtCVJcuAAAgB6d46i
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMUmxtEwBNtp0DUwS03RNLMzSdC2BtbhuqkWyebJhcmKaCXhTmK-fmUeoiVeEaQQTQw5sLwz4nNBy8OGIwByVDMzvJeDyugAxiOUCXltZrJ-UCRTKt3cLsXVRg_aOgZ0PYBdGzcXJ1jXA38XfWc3Z2dY7SM0vCCwHOl0PKO_IzMBqDjqfF9R4CnMC7UspQK5U3AQZ2AKA5uWVCDEwZecLM3A6w-5eE2bg8IVOeQOZ0NxXLMKg93p5x9vGNa8XznnTPedt45bXy9YqvJ055e3Ula_X7FF4vaFf4dX2HW_mzlB4M2vl6_4WUQZlN9cQZw9doMXxcH_Gewchu9JYjIElLz8vVYJBITXZxCLV3DjRMDkJ2HxJNLVIAjYC0oxNkhLNEhNNkxMlGWTwmSSFX1qegdMjxNcn3sfTz1uagQskBVqvYWggw8BSUlSaKgusdUuS5MCBBQBO8JGP
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%EB%A7%88%ED%81%AC%EB%A1%9C%EC%8B%9C%ED%81%B4%EB%A6%AD+%ED%99%94%ED%95%A9%EB%AC%BC+%EB%B0%8F+%EA%B7%B8%EC%9D%98+%EC%9A%A9%EB%8F%84&rft.inventor=KISHI+YOSHITO&rft.inventor=KIRA+KAZUNOBU&rft.inventor=ITO+KEN&rft.date=2019-12-10&rft.externalDBID=A&rft.externalDocID=KR20190137121A